These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 24922669
1. XRCC1 rs25487 polymorphism predicts the survival of patients after postoperative radiotherapy and adjuvant chemotherapy for breast cancer. Tengström M, Mannermaa A, Kosma VM, Hirvonen A, Kataja V. Anticancer Res; 2014 Jun; 34(6):3031-7. PubMed ID: 24922669 [Abstract] [Full Text] [Related]
2. Association of the Arg194Trp and the Arg399Gln polymorphisms of the XRCC1 gene with risk occurrence and the response to adjuvant therapy among Polish women with breast cancer. Przybylowska-Sygut K, Stanczyk M, Kusinska R, Kordek R, Majsterek I. Clin Breast Cancer; 2013 Feb; 13(1):61-8. PubMed ID: 23103366 [Abstract] [Full Text] [Related]
3. XRCC1 gene polymorphism for prediction of response and prognosis in the multimodality therapy of patients with locally advanced rectal cancer. Grimminger PP, Brabender J, Warnecke-Eberz U, Narumiya K, Wandhöfer C, Drebber U, Bollschweiler E, Hölscher AH, Metzger R, Vallböhmer D. J Surg Res; 2010 Nov; 164(1):e61-6. PubMed ID: 20863523 [Abstract] [Full Text] [Related]
4. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods. Skowronek J, Piotrowski T. Neoplasma; 2002 Nov; 49(6):426-31. PubMed ID: 12584593 [Abstract] [Full Text] [Related]
5. Does immediate breast reconstruction after mastectomy and neoadjuvant chemotherapy influence the outcome of patients with non-endocrine responsive breast cancer? Aurilio G, Bagnardi V, Graffeo R, Nolè F, Petit JY, Locatelli M, Martella S, Iera M, Rey P, Curigliano G, Rotmensz N, Munzone E, Goldhirsch A. Anticancer Res; 2014 Nov; 34(11):6677-83. PubMed ID: 25368274 [Abstract] [Full Text] [Related]
11. Patterns of care with regard to surgical choice and application of adjuvant radiation therapy for preinvasive and early stage breast cancer in rural Appalachia. Freeman AB, Huang B, Dragun AE. Am J Clin Oncol; 2012 Aug; 35(4):358-63. PubMed ID: 21422902 [Abstract] [Full Text] [Related]
15. The combination of ERCC1 and XRCC1 gene polymorphisms better predicts clinical outcome to oxaliplatin-based chemotherapy in metastatic colorectal cancer. Liang J, Jiang T, Yao RY, Liu ZM, Lv HY, Qi WW. Cancer Chemother Pharmacol; 2010 Aug; 66(3):493-500. PubMed ID: 19960344 [Abstract] [Full Text] [Related]
16. XRCC1 and ADPRT polymorphisms associated with survival in breast cancer cases treated with chemotherapy. Ye S, Rong J, Huang SH, Zheng ZS, Yun M, Wang SM. Asian Pac J Cancer Prev; 2012 Aug; 13(10):4923-6. PubMed ID: 23244082 [Abstract] [Full Text] [Related]
20. DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy. Ott K, Rachakonda PS, Panzram B, Keller G, Lordick F, Becker K, Langer R, Buechler M, Hemminki K, Kumar R. Ann Surg Oncol; 2011 Sep; 18(9):2688-98. PubMed ID: 21347786 [Abstract] [Full Text] [Related] Page: [Next] [New Search]